![Graham McNeil](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Graham McNeil is currently the Chairman at Bristol-Myers Squibb FCT bêta, Inc. He has a graduate degree from the University of Toronto.
| Companies | Position | End |
|---|---|---|
Bristol-Myers Squibb FCT bêta, Inc.
 Bristol-Myers Squibb FCT bêta, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-tumor activity medication treatment | Chairman | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 2 |
|---|---|
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bristol-Myers Squibb FCT bêta, Inc.
Bristol-Myers Squibb FCT bêta, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-tumor activity medication treatment | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
